- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.10. | AbbVie signs agreement to acquire Aliada for $1.4bn | ||
| 28.10. | Preparing for DSCSA transition with tech-led compliance | ||
| 28.10. | FDA grants ODD to Modalis' MDL-101 to treat LAMA2-CMD | ||
| 28.10. | Redlining's lasting impact on asthma disparities | ||
| 28.10. | EU Critical Medicines Act: closer to ending overreliance on Asian manufacturers | ||
| 28.10. | UAE's clinical trials space matures with experience from Covid-19 | ||
| 28.10. | FDA approves Iterum's ORLYNVAH NDA for uUTI treatment | ||
| 28.10. | Social media engagement boosts rare disease outreach | ||
| 28.10. | Astellas withdraws Europe ACP application for AMD treatment | ||
| 25.10. | Pharma companies must adapt to keep pace with AI developments, say experts | ||
| 25.10. | AF stroke patients could benefit from earlier anticoagulant administration | ||
| 25.10. | LEO's Adbry demonstrates long-term efficacy in atopic dermatitis | ||
| 25.10. | GSK pumps up to $800m for US manufacturing site upgrade | ||
| 25.10. | Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline | ||
| 25.10. | Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments | ||
| 25.10. | Dyno and Roche collaborate on neurological gene therapies | ||
| 25.10. | Takeda and BMC partner to decarbonise US healthcare sector | ||
| 25.10. | AbbVie and Richter partner for neuropsychiatric treatments | ||
| 24.10. | US CDC AdCom recommends lowering the age for pneumococcal vaccines | ||
| 24.10. | Alpha-9 becomes latest radiopharma to secure funds with $175m Series C | ||
| 24.10. | Pharmacists "desperation" by Novo Nordisk over semaglutide copycat block | ||
| 24.10. | Futureproofing supply chains in an evolving pharmaceutical industry? | ||
| 24.10. | MSD acquires cancer therapeutics developer Modifi Biosciences | ||
| 24.10. | Opioid treatment market set to grow despite expected slump in US sale value | ||
| 24.10. | Transforming CML patient monitoring with ICON's innovative RNA-based NGS assay |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
